Mauer and colleagues demonstrated that inactivation of IL-6R/IL-6 signaling in myeloid cells of experimental animals attenuates obesity-induced inflammation and insulin resistance by promoting M2 macrophage alternative activation. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.